Overview
| Research | Process | Pre-clinical | Phase 1 | Phase 2 | Phase 3 | ||
|---|---|---|---|---|---|---|---|
| ALT-P1 | Long-acting Human Growth Hormone |  |
|
|
|
|
|
| Domestic Phase II in Progress / Preparation of global Phase II | |||||||
| ALT-P7 | Breast/Gastric Cancer ADC | |
|
|
|
||
| Domestic Phase I completed | |||||||
| ALT-Q5 | Ovarian Cancer ADC | |
|
||||
| Process Development in Progress | |||||||
| ALT-L9 | Eylea Biosimilar | |
|
|
|
|
|
| Global Phase III Clinical Trial in Progress | |||||||
| ALT-L2 | Herceptin Biosimilar | |
|
|
|
|
|
| BLA in China | |||||||
